Mechanism of Action: Cytochrome P450 2D6 Inducers
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Drugs with Mechanism of Action: Cytochrome P450 2D6 Inducers
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acella | PHENYTOIN SODIUM | phenytoin sodium | INJECTABLE;INJECTION | 040573-001 | Sep 13, 2006 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Aurobindo Pharma | PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 204309-001 | Jun 10, 2015 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
West-ward Pharms Int | PHENYTOIN SODIUM | phenytoin sodium | INJECTABLE;INJECTION | 084307-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |